| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.04 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |